All 107 SBIO (ALPS MEDICAL BREAKTHROUGHS ETF) Holdings
There are 107 SBIO holdings. Top 10 companies weight: 31.00%.
Total Market Cap: $166B
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (107 stocks) | +3.26% | 11.23 | 5.82 | 0.26 | +62.76% | +2.07% | 1.17 | ||||||||||
1 | CRNX | Crinetics Pharmaceuticals Inc | 4.38% | $83.87 | $8.84B | Biotechnology | Healthcare | +16.22% | N/A | N/A | N/A | N/A | N/A | 78 | -1.63% | $83 | +33.54% | 1.02 |
2 | APGE | Apogee Therapeutics Inc | 4.11% | $134.15 | $10B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 69 | -2.70% | $131 | 0.00% | 1.25 |
3 | XENE | Xenon Pharmaceuticals Inc | 3.41% | $66.04 | $6.54B | Biotechnology | Healthcare | +40.27% | N/A | N/A | N/A | N/A | N/A | 78 | +21.99% | $81 | +29.09% | 0.92 |
4 | CGON | Cg Oncology Inc | 3.22% | $70.19 | $6.42B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +28.64% | $90 | 0.00% | 1.46 |
5 | DNTH | Dianthus Therapeutics Inc | 2.72% | $101 | $5.45B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +27.31% | $129 | 0.00% | 1.11 |
6 | TVTX | Travere Therapeutics Inc Ordinary Shares | 2.70% | $55.47 | $5.24B | Biotechnology | Healthcare | -44.12% | N/A | 77.52 | N/A | N/A | N/A | 76 | +5.21% | $58 | +32.19% | 1.28 |
7 | ORKA | Oruka Therapeutics Inc | 2.65% | $91.71 | $4.35B | Biotechnology | Healthcare | +11.91% | N/A | N/A | N/A | N/A | N/A | 78 | +57.75% | $145 | +31.48% | N/A |
8 | DFTX | N/A | 2.63% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
9 | MANE | Veradermics Inc | 2.59% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
10 | EWTX | Edgewise Therapeutics Inc | 2.59% | $38.81 | $4.39B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +28.63% | $50 | +13.70% | 1.37 |
11 | ACAD | Acadia Pharmaceuticals Inc | 2.25% | $25.09 | $4.43B | Biotechnology | Healthcare | N/A | 11.73 | 76.34 | 0.19 | N/A | N/A | 72 | +30.13% | $33 | +1.12% | 0.90 |
12 | RLAY | Relay Therapeutics Inc Ordinary Shares | 2.25% | $19.18 | $3.69B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +32.33% | $25 | -11.08% | 1.84 |
13 | DNLI | Denali Therapeutics Inc | 2.15% | $22.90 | $3.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +49.56% | $34 | -18.93% | 1.45 |
14 | NAMS | Newamsterdam Pharma Co Nv | 2.09% | $29.67 | $3.73B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +67.98% | $50 | 0.00% | 1.00 |
15 | DYN | Dyne Therapeutics Inc Ordinary Shares | 2.00% | $23.45 | $3.96B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +67.16% | $39 | +3.77% | 1.77 |
16 | GPCR | Structure Therapeutics Inc Adr | 1.95% | $46.98 | $3.53B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 79 | +122.63% | $105 | 0.00% | 0.83 |
17 | IDYA | Ideaya Biosciences Inc | 1.63% | $35.45 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +47.50% | $52 | +10.45% | 1.10 |
18 | MBX | Mbx Biosciences Inc | 1.55% | $60.14 | $2.89B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +14.73% | $69 | 0.00% | 1.44 |
19 | VERA | Vera Therapeutics Inc Class A | 1.52% | $36.99 | $3.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +121.11% | $82 | +17.52% | 1.22 |
20 | CLDX | Celldex Therapeutics Inc | 1.52% | $35.42 | $2.55B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +62.42% | $58 | -3.94% | 1.17 |
21 | IRON | Disc Medicine Inc Ordinary Shares | 1.50% | $74.38 | $2.90B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +36.53% | $102 | +6.97% | 1.15 |
22 | TARS | N/A | 1.37% | $56.25 | $2.47B | Biotechnology | Healthcare | N/A | N/A | 106.38 | N/A | N/A | N/A | 77 | +68.11% | $95 | +16.34% | 0.61 |
23 | BCRX | Biocryst Pharmaceuticals Inc | 1.36% | $9.11 | $2.39B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 86.96 | N/A | N/A | N/A | 82 | +130.52% | $21 | -11.23% | 0.77 |
24 | KLRA | Kailera Therapeutics Inc | 1.36% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
25 | IMNM | Immunome Inc Ordinary Shares | 1.36% | $22.16 | $2.59B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +61.42% | $36 | +4.86% | 1.64 |
26 | MLYS | Mineralys Therapeutics Inc | 1.27% | $26.71 | $2.43B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +83.45% | $49 | 0.00% | 0.76 |
27 | AGIO | Agios Pharmaceuticals Inc | 1.27% | $40.06 | $2.37B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +6.39% | $43 | -6.30% | 1.02 |
28 | SLS | Sellas Life Sciences Group Inc | 1.25% | $12.48 | $2.32B | Biotechnology | Healthcare | -32.56% | N/A | N/A | N/A | N/A | N/A | 87 | +120.44% | $28 | +6.05% | 0.90 |
29 | NKTR | Nektar Therapeutics | 1.23% | $64.84 | $1.69B | Biotechnology | Healthcare | -24.01% | N/A | 34.01 | 0.31 | N/A | N/A | 75 | +136.35% | $153 | -23.76% | 1.81 |
30 | VCEL | Vericel Corp | 1.23% | $45.88 | $2.38B | Biotechnology | Healthcare | +35.66% | 109.92 | 98.04 | 0.18 | N/A | N/A | 71 | +24.54% | $57 | -3.35% | 1.13 |
31 | VRDN | Viridian Therapeutics Inc | 1.11% | $18.56 | $1.95B | Biotechnology | Healthcare | -32.36% | N/A | 1.01 | N/A | N/A | N/A | 79 | +94.61% | $36 | +1.88% | 1.08 |
32 | ZLAB | Zai Lab Ltd Adr Repr 1 Shs | 1.09% | $20.52 | $2.27B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +62.28% | $33 | -33.36% | 0.91 |
33 | SRPT | Sarepta Therapeutics Inc | 1.08% | $16.83 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.01 | 159.25 | N/A | N/A | 48 | +31.73% | $22 | -24.47% | 1.40 |
34 | PVLA | Palvella Therapeutics Inc | 1.07% | $124.15 | $2.18B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +84.94% | $230 | 0.00% | 1.01 |
35 | NUVB | N/A | 1.06% | $6.26 | $2.04B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +96.96% | $12 | -6.73% | 1.47 |
36 | AMLX | Amylyx Pharmaceuticals Inc | 1.02% | $17.45 | $1.97B | Drug Manufacturers - Specialty & Generic | Healthcare | N/A | N/A | 2.77 | N/A | N/A | N/A | 72 | +39.83% | $24 | 0.00% | 1.14 |
37 | STOK | Stoke Therapeutics Inc | 1.02% | $27.68 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +65.53% | $46 | -3.27% | 1.04 |
38 | SION | Sionna Therapeutics Inc | 1.01% | $45.69 | $2B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 68 | +12.93% | $52 | 0.00% | 0.90 |
39 | GENB | Generate Biomedicines Inc | 1.00% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
40 | RAPP | Rapport Therapeutics Inc | 1.00% | $40.21 | $1.91B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +40.86% | $57 | 0.00% | 1.26 |
41 | LKFT | Lakefront Biotherapeutics Nv Adr | 0.99% | - | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
42 | TYRA | Tyra Biosciences Inc | 0.98% | $31.06 | $1.93B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +67.35% | $52 | 0.00% | 1.01 |
43 | BCAX | Bicara Therapeutics Inc | 0.97% | $27.15 | $1.84B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +15.87% | $31 | 0.00% | 1.40 |
44 | TSHA | N/A | 0.94% | $5.58 | $1.78B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +132.97% | $13 | -22.80% | 1.42 |
45 | ZBIO | Zenas Biopharma Inc | 0.92% | $30.70 | $1.83B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +37.20% | $42 | 0.00% | 1.24 |
46 | CMPS | Compass Pathways Plc Adr | 0.91% | $11.67 | $1.80B | Medical Care Facilities | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +109.68% | $24 | -20.66% | 1.38 |
47 | MAZE | Maze Therapeutics Inc | 0.89% | $28.37 | $1.46B | Biotechnology | Healthcare | N/A | N/A | 8.53 | N/A | N/A | N/A | 77 | +120.48% | $63 | 0.00% | 0.87 |
48 | IMCR | Immunocore Holdings Plc Adr | 0.84% | $34.05 | $1.76B | Biotechnology | Healthcare | N/A | N/A | 232.56 | N/A | N/A | N/A | 69 | +86.11% | $63 | -0.94% | 0.70 |
49 | AVBP | Arrivent Biopharma Inc | 0.78% | $28.22 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +54.64% | $44 | 0.00% | 0.94 |
50 | CRVS | Corvus Pharmaceuticals Inc | 0.68% | $14.10 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +136.38% | $33 | +43.22% | 0.75 |
SBIO (ALPS MEDICAL BREAKTHROUGHS ETF) Sector Allocation
HEALTHCARE
89.80%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%